General Information
Product name
Company
Subspeciality
Modality
Disease targeted
Main task
Not specified
Technical Specifications
Population
Patient population age
Not specified
Input
Input format
Output
Output format
Integration
Deployment
Trigger for analysis
Processing time
Regulatory Information
Pathway:
MDD
Class:
Class IIa
Pathway:
510(k) cleared
Class:
Class II
Other certifications
Not specified
Market Presence
On market since
AI Platforms
Resellers
Not specified
Countries present
Paying clinical customers
Research/test users
Pricing Information
Pricing model
Based on
Evidence & Research
Other Articles
View
Quantitative Emphysema on Low-Dose CT Imaging of the Chest and Risk of Lung Cancer and Airflow Obstruction: An Analysis of the National Lung Screening Trial
Source: vendor | First published: Feb 25, 2024 | Last updated: Jul 9, 2025